Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD7054 |
Approved |
0.9937 |
High Similarity |
NPD7472 |
Approved |
0.9812 |
High Similarity |
NPD7074 |
Phase 3 |
0.9691 |
High Similarity |
NPD7251 |
Discontinued |
0.9632 |
High Similarity |
NPD7808 |
Phase 3 |
0.963 |
High Similarity |
NPD6797 |
Phase 2 |
0.9325 |
High Similarity |
NPD3818 |
Discontinued |
0.9277 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9202 |
High Similarity |
NPD6166 |
Phase 2 |
0.9202 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9202 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9187 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9152 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9057 |
High Similarity |
NPD1934 |
Approved |
0.8882 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD2801 |
Approved |
0.8712 |
High Similarity |
NPD3817 |
Phase 2 |
0.8671 |
High Similarity |
NPD1511 |
Approved |
0.858 |
High Similarity |
NPD4380 |
Phase 2 |
0.8562 |
High Similarity |
NPD1512 |
Approved |
0.8545 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8545 |
High Similarity |
NPD3882 |
Suspended |
0.8439 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8383 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8382 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8232 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8208 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8155 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8095 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8095 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8057 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8046 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8034 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8034 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8022 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7988 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7977 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7952 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7937 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7912 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7874 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7772 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.776 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7747 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7719 |
Intermediate Similarity |
NPD37 |
Approved |
0.7706 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7688 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7688 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7683 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6780 |
Approved |
0.761 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7604 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7604 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7604 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7604 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD919 |
Approved |
0.7593 |
Intermediate Similarity |
NPD1607 |
Approved |
0.759 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD943 |
Approved |
0.7562 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7528 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7461 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7443 |
Intermediate Similarity |
NPD3749 |
Approved |
0.744 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7435 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7435 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7396 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7382 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6534 |
Approved |
0.736 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD2533 |
Approved |
0.731 |
Intermediate Similarity |
NPD2534 |
Approved |
0.731 |
Intermediate Similarity |
NPD2532 |
Approved |
0.731 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7296 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7296 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7234 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD920 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD6651 |
Approved |
0.716 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7117 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.711 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7093 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7033 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7016 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD2344 |
Approved |
0.6982 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6976 |
Remote Similarity |
NPD7930 |
Approved |
0.6966 |
Remote Similarity |
NPD6386 |
Approved |
0.6966 |
Remote Similarity |
NPD6385 |
Approved |
0.6966 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6957 |
Remote Similarity |
NPD5242 |
Approved |
0.6949 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD5005 |
Approved |
0.6935 |
Remote Similarity |
NPD5006 |
Approved |
0.6931 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6928 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6928 |
Remote Similarity |
NPD3268 |
Approved |
0.6923
|
Remote Similarity |
NPD7097 |
Phase 1 |